Literature DB >> 29843945

Isolation of biofunctional bovine immunoglobulin G from milk- and colostral whey with mixed-mode chromatography at lab and pilot scale.

Hans-Jürgen Heidebrecht1, Bernadette Kainz2, Roland Schopf2, Klaus Godl3, Züleyha Karcier3, Ulrich Kulozik4, Beatrix Förster5.   

Abstract

The aim of the present work was to develop a new scalable and cost-efficient process to isolate bovine immunoglobulin G from colostral whey with high purity and minimal loss of activity. The mixed mode material Mercapto-Ethyl-Pyridine-Hypercel™ was identified appropriate for direct capture of immunoglobulin G. The binding mechanism is primarily based on hydrophobic interactions at physiological conditions. As compared to immunoglobulin G, all other low molecular whey proteins such as α-Lactalbumin or β-Lactoglobulin, except lactoperoxidase, are more hydrophilic and were therefore found in the flow-through fraction. In order to remove lactoperoxidase as an impurity the column was combined in series with a second mixed mode material (Capto™- with N-benzoyl-homocysteine as ligand) using the same binding conditions. At pH 7.5 the carboxyl group of this ligand is negatively charged and can hence bind the positively charged lactoperoxidase, whose isoelectric point is at pH 9.6. After sample application, the columns were eluted separately. By combining the two columns it was possible to obtain immunoglobulin G with a purity of >96.1% and yield of 65-80%. The process development was carried out using 1 mL columns and upscaling was performed in three steps up to a column volume of 8800 mL for the Hypercel™ column and 3000 mL for the Capto™- column. At this scale it is possible to obtain 130-150 g pure immunoglobulin G from 3 L colostrum within five hours, including the regeneration of both columns. Additionally, the impact of freeze-drying on the isolated immunoglobulin G was studied. The nativity of the freeze dried immunoglobulin was above 95%, which was proven by reversed phase liquid chromatography and validated by differential scanning calorimetry. The activity of immunoglobulin G was preserved over the isolation process and during drying as measured by enzyme-linked immunosorbent assay. In conclusion, by applying the proposed isolation process, it becomes feasible to obtain pure, active and stable imunnunoglobulin G at large scale.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hydrophobic charge-induction chromatography; Immunoglobulin G; Mixed-mode chromatography; Whey proteins

Mesh:

Substances:

Year:  2018        PMID: 29843945     DOI: 10.1016/j.chroma.2018.05.046

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  4 in total

1.  Treatment and Prevention of Recurrent Clostridium difficile Infection with Functionalized Bovine Antibody-Enriched Whey in a Hamster Primary Infection Model.

Authors:  Hans-Jürgen Heidebrecht; William J Weiss; Mark Pulse; Anton Lange; Karina Gisch; Heike Kliem; Sacha Mann; Michael W Pfaffl; Ulrich Kulozik; Christoph von Eichel-Streiber
Journal:  Toxins (Basel)       Date:  2019-02-06       Impact factor: 4.546

2.  Data concerning the fractionation of individual whey proteins and casein micelles by microfiltration with ceramic gradient membranes.

Authors:  Hans-Jürgen Heidebrecht; Ulrich Kulozik
Journal:  Data Brief       Date:  2019-06-05

3.  Data concerning the chromatographic isolation of bovine IgG from milk- and colostral whey.

Authors:  Hans-Jürgen Heidebrecht; Bernadette Kainz; Roland Schopf; Klaus Godl; Züleyha Karcier; Ulrich Kulozik; Beatrix Förster
Journal:  Data Brief       Date:  2018-10-05

Review 4.  Insights into the Research Trends on Bovine Colostrum: Beneficial Health Perspectives with Special Reference to Manufacturing of Functional Foods and Feed Supplements.

Authors:  Rahul Mehra; Renu Garhwal; Karnam Sangwan; Raquel P F Guiné; Edite Teixeira Lemos; Harpal Singh Buttar; Pradeep Kumar Singh Visen; Naveen Kumar; Anuradha Bhardwaj; Harish Kumar
Journal:  Nutrients       Date:  2022-02-04       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.